CYTOSORBENTS CORPORATION Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
CYTOSORBENTS CORPORATION (CTSO) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of 1.00% for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-31.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2015-03-31
- CYTOSORBENTS CORPORATION effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2014 was 1.00%, a 65.52% decline from fiscal 2013.
- CYTOSORBENTS CORPORATION effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2013 was 2.90%, a 34.09% decline from fiscal 2012.
- CYTOSORBENTS CORPORATION effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2012 was 4.40%, a 25.42% decline from fiscal 2011.
- CYTOSORBENTS CORPORATION effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2011 was 5.90%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month |
|---|---|
| 2014-12-31 | 1.00% 10-K · filed 2015-03-31 |
| 2013-12-31 | 2.90% 10-K · filed 2015-03-31 |
| 2012-12-31 | 4.40% 10-K · filed 2014-03-31 |
| 2011-12-31 | 5.90% 10-K · filed 2013-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |